| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 5 | 2022 | 54 | 2.550 |
Why?
|
| T-Lymphocytes | 24 | 2016 | 280 | 2.250 |
Why?
|
| Cell Differentiation | 12 | 2020 | 398 | 1.200 |
Why?
|
| ras Proteins | 7 | 2011 | 43 | 1.110 |
Why?
|
| Lymphocyte Activation | 15 | 2016 | 204 | 1.000 |
Why?
|
| Antigens, CD | 16 | 2020 | 134 | 0.970 |
Why?
|
| Mucosal-Associated Invariant T Cells | 1 | 2022 | 3 | 0.780 |
Why?
|
| Immunity, Innate | 2 | 2022 | 211 | 0.740 |
Why?
|
| Receptors, Antigen, T-Cell | 12 | 2022 | 75 | 0.710 |
Why?
|
| Thymus Gland | 9 | 2011 | 53 | 0.710 |
Why?
|
| Signal Transduction | 17 | 2024 | 1374 | 0.700 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 56 | 0.700 |
Why?
|
| Transcription Factor 4 | 1 | 2019 | 5 | 0.680 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2004 | 83 | 0.680 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2006 | 95 | 0.660 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 54 | 0.650 |
Why?
|
| Retroviridae | 3 | 2016 | 16 | 0.600 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2011 | 101 | 0.580 |
Why?
|
| Dendritic Cells | 2 | 2016 | 143 | 0.550 |
Why?
|
| Genetic Vectors | 2 | 2016 | 107 | 0.550 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 24 | 0.540 |
Why?
|
| West Nile virus | 1 | 2016 | 20 | 0.530 |
Why?
|
| Cell Lineage | 2 | 2011 | 45 | 0.530 |
Why?
|
| Mice | 21 | 2024 | 4467 | 0.530 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2016 | 7 | 0.520 |
Why?
|
| Animals | 27 | 2024 | 10069 | 0.510 |
Why?
|
| Mice, Transgenic | 11 | 2020 | 490 | 0.500 |
Why?
|
| Ovary | 2 | 2024 | 69 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 6 | 2001 | 26 | 0.440 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 2020 | 19 | 0.390 |
Why?
|
| GATA3 Transcription Factor | 1 | 2011 | 2 | 0.370 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 93 | 0.350 |
Why?
|
| Protein Kinases | 4 | 2004 | 147 | 0.290 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 627 | 0.270 |
Why?
|
| Aging | 2 | 2024 | 960 | 0.260 |
Why?
|
| Gene Knock-In Techniques | 2 | 2019 | 18 | 0.260 |
Why?
|
| Proteins | 3 | 2005 | 245 | 0.260 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2006 | 134 | 0.260 |
Why?
|
| B-Lymphocytes | 4 | 2006 | 278 | 0.260 |
Why?
|
| Calcium Signaling | 1 | 2006 | 68 | 0.250 |
Why?
|
| Lymphoid Progenitor Cells | 2 | 2019 | 4 | 0.250 |
Why?
|
| CD5 Antigens | 7 | 2014 | 12 | 0.240 |
Why?
|
| Humans | 32 | 2024 | 27143 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2008 | 91 | 0.240 |
Why?
|
| Clonal Deletion | 2 | 2008 | 2 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 9 | 1998 | 318 | 0.230 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 195 | 0.220 |
Why?
|
| Cellular Senescence | 1 | 2024 | 121 | 0.210 |
Why?
|
| Mice, Knockout | 6 | 2011 | 792 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 31 | 0.210 |
Why?
|
| CD3 Complex | 5 | 2000 | 23 | 0.210 |
Why?
|
| Protein Kinase C | 10 | 1999 | 72 | 0.200 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 2001 | 18 | 0.190 |
Why?
|
| Adaptive Immunity | 1 | 2022 | 37 | 0.190 |
Why?
|
| Receptors, Immunologic | 2 | 1993 | 64 | 0.190 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 2 | 2011 | 2 | 0.190 |
Why?
|
| Antigens, Differentiation | 7 | 1998 | 21 | 0.190 |
Why?
|
| Enzyme Activation | 9 | 2006 | 264 | 0.180 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 109 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 1494 | 0.180 |
Why?
|
| Early Growth Response Protein 2 | 2 | 2011 | 2 | 0.170 |
Why?
|
| Sarcoma, Experimental | 1 | 2020 | 2 | 0.170 |
Why?
|
| Lymphoma, T-Cell | 1 | 2020 | 7 | 0.170 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 29 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2003 | 468 | 0.170 |
Why?
|
| Inflammation | 1 | 2024 | 605 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2011 | 68 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 45 | 0.160 |
Why?
|
| Immunophenotyping | 2 | 2016 | 59 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2016 | 975 | 0.160 |
Why?
|
| Apoptosis | 3 | 2020 | 738 | 0.160 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1998 | 9 | 0.160 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 12 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 185 | 0.150 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2016 | 3 | 0.140 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2016 | 12 | 0.140 |
Why?
|
| West Nile Fever | 1 | 2016 | 15 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2016 | 28 | 0.130 |
Why?
|
| Cell Line | 4 | 2016 | 679 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2016 | 54 | 0.130 |
Why?
|
| Virus Replication | 1 | 2016 | 62 | 0.130 |
Why?
|
| DNA Primers | 4 | 2014 | 143 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 341 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2016 | 67 | 0.130 |
Why?
|
| Base Sequence | 5 | 2014 | 573 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 61 | 0.130 |
Why?
|
| Female | 7 | 2024 | 14634 | 0.130 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2011 | 9 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 153 | 0.120 |
Why?
|
| Flow Cytometry | 7 | 2014 | 285 | 0.120 |
Why?
|
| Phenotype | 2 | 2016 | 666 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 283 | 0.120 |
Why?
|
| Protein Binding | 1 | 2016 | 635 | 0.120 |
Why?
|
| Cytokines | 1 | 2016 | 439 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2014 | 6 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 57 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 45 | 0.110 |
Why?
|
| Antigenic Modulation | 1 | 1993 | 1 | 0.110 |
Why?
|
| Biomarkers | 1 | 2016 | 736 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2011 | 514 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 8 | 1998 | 31 | 0.100 |
Why?
|
| Precipitin Tests | 7 | 1998 | 47 | 0.100 |
Why?
|
| Male | 5 | 2020 | 13017 | 0.100 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 1 | 2011 | 1 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2011 | 3 | 0.090 |
Why?
|
| Calcineurin | 1 | 2011 | 7 | 0.090 |
Why?
|
| Antigens, CD1d | 1 | 2011 | 45 | 0.090 |
Why?
|
| Integrases | 1 | 2011 | 39 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2011 | 176 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 482 | 0.090 |
Why?
|
| Interleukin-2 | 5 | 1997 | 33 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 5 | 1998 | 64 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2009 | 26 | 0.080 |
Why?
|
| Interferon Regulatory Factors | 1 | 2009 | 58 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2008 | 240 | 0.080 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 2001 | 7 | 0.080 |
Why?
|
| Spleen | 3 | 1998 | 109 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2001 | 161 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 1999 | 675 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 1999 | 1037 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 205 | 0.070 |
Why?
|
| RNA, Messenger | 6 | 1998 | 647 | 0.070 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2006 | 14 | 0.070 |
Why?
|
| Calcium | 3 | 1998 | 232 | 0.060 |
Why?
|
| Pokeweed Mitogens | 2 | 1997 | 3 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2001 | 33 | 0.060 |
Why?
|
| Puromycin | 1 | 2004 | 1 | 0.060 |
Why?
|
| RNA Interference | 1 | 2005 | 135 | 0.060 |
Why?
|
| Monocytes | 3 | 1997 | 132 | 0.060 |
Why?
|
| Cell Movement | 1 | 2006 | 353 | 0.060 |
Why?
|
| Oocytes | 1 | 2024 | 24 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 88 | 0.060 |
Why?
|
| Reproduction | 1 | 2024 | 63 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 204 | 0.060 |
Why?
|
| Fertility | 1 | 2024 | 58 | 0.050 |
Why?
|
| Type C Phospholipases | 3 | 1999 | 31 | 0.050 |
Why?
|
| Isoenzymes | 3 | 1999 | 86 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2003 | 44 | 0.050 |
Why?
|
| CD2 Antigens | 2 | 1993 | 3 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 121 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1992 | 7 | 0.050 |
Why?
|
| Protein Biosynthesis | 3 | 1997 | 109 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 15 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 1992 | 103 | 0.050 |
Why?
|
| Phospholipase C gamma | 2 | 1997 | 13 | 0.040 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2020 | 2 | 0.040 |
Why?
|
| Leukopoiesis | 1 | 2000 | 2 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2000 | 13 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2000 | 20 | 0.040 |
Why?
|
| CD28 Antigens | 1 | 2000 | 11 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2000 | 30 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2000 | 58 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 123 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2000 | 64 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 1999 | 8 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 1999 | 4 | 0.040 |
Why?
|
| Phosphorylation | 4 | 1993 | 566 | 0.040 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1999 | 13 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 1997 | 33 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2001 | 246 | 0.040 |
Why?
|
| Oncogene Proteins v-raf | 1 | 1998 | 1 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 143 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 408 | 0.040 |
Why?
|
| Ionomycin | 1 | 1998 | 4 | 0.040 |
Why?
|
| fas Receptor | 1 | 1998 | 20 | 0.040 |
Why?
|
| Stem Cells | 1 | 1999 | 113 | 0.040 |
Why?
|
| Alleles | 1 | 1999 | 347 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 1998 | 77 | 0.040 |
Why?
|
| Mutation | 2 | 2001 | 821 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1993 | 240 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 262 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1997 | 3 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 43 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 254 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1997 | 48 | 0.030 |
Why?
|
| Cell Division | 2 | 2001 | 153 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1996 | 9 | 0.030 |
Why?
|
| Models, Biological | 1 | 1998 | 448 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 2 | 1993 | 17 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1269 | 0.030 |
Why?
|
| Inositol Phosphates | 2 | 1992 | 6 | 0.030 |
Why?
|
| Child | 4 | 1999 | 2165 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 3 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1995 | 36 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 11 | 0.030 |
Why?
|
| Blotting, Western | 4 | 2004 | 506 | 0.030 |
Why?
|
| Antigens, Surface | 2 | 1991 | 39 | 0.030 |
Why?
|
| Peptides | 1 | 1996 | 280 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 1993 | 17 | 0.030 |
Why?
|
| Calmodulin | 1 | 1993 | 9 | 0.030 |
Why?
|
| Serine | 1 | 1993 | 47 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1992 | 83 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 1993 | 9 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1990 | 101 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 310 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 1993 | 40 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1990 | 79 | 0.030 |
Why?
|
| Epitopes | 2 | 1990 | 177 | 0.030 |
Why?
|
| Diglycerides | 1 | 1992 | 10 | 0.020 |
Why?
|
| Diterpenes | 1 | 1992 | 19 | 0.020 |
Why?
|
| Blotting, Northern | 3 | 1998 | 46 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1997 | 165 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1991 | 8 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 1990 | 29 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 1989 | 5 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2009 | 19 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 58 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2009 | 27 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2009 | 42 | 0.020 |
Why?
|
| Kinetics | 4 | 1992 | 538 | 0.020 |
Why?
|
| Neutrophils | 1 | 1990 | 179 | 0.020 |
Why?
|
| Estrogens | 1 | 2009 | 56 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 80 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 1999 | 29 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 174 | 0.020 |
Why?
|
| Molecular Weight | 3 | 1997 | 118 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1995 | 988 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 229 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 394 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 1998 | 42 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 1997 | 399 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1993 | 111 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1992 | 38 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 6 | 0.010 |
Why?
|
| Alkaloids | 2 | 1992 | 16 | 0.010 |
Why?
|
| Staurosporine | 2 | 1992 | 10 | 0.010 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2001 | 11 | 0.010 |
Why?
|
| Enterotoxins | 1 | 2001 | 21 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 45 | 0.010 |
Why?
|
| Mitogens | 2 | 1990 | 3 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1990 | 13 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1999 | 3 | 0.010 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 1999 | 2 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 6 | 0.010 |
Why?
|
| Transgenes | 1 | 1999 | 59 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 262 | 0.010 |
Why?
|
| Clone Cells | 1 | 1998 | 20 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1999 | 187 | 0.010 |
Why?
|
| Cell Separation | 1 | 1998 | 55 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1997 | 11 | 0.010 |
Why?
|
| Genomic Library | 1 | 1997 | 10 | 0.010 |
Why?
|
| Exons | 1 | 1997 | 41 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1997 | 31 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 27 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 312 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 130 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 111 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1997 | 3 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1997 | 115 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1995 | 6 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1995 | 30 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 278 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 122 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 139 | 0.010 |
Why?
|
| Adult | 2 | 1997 | 7498 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1993 | 10 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1993 | 57 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1993 | 2 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1993 | 36 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1993 | 135 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1992 | 20 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1992 | 2 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1992 | 2 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1992 | 5 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 4 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1992 | 14 | 0.010 |
Why?
|
| Terpenes | 1 | 1992 | 9 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 365 | 0.010 |
Why?
|
| Piperazines | 1 | 1992 | 45 | 0.010 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 1991 | 1 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1992 | 197 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1990 | 2 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1990 | 26 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1990 | 1 | 0.010 |
Why?
|
| DNA Replication | 1 | 1991 | 49 | 0.010 |
Why?
|
| Carcinogens | 1 | 1990 | 37 | 0.010 |
Why?
|
| RNA | 1 | 1990 | 105 | 0.010 |
Why?
|
| Adolescent | 1 | 1995 | 2991 | 0.000 |
Why?
|
| Middle Aged | 1 | 1995 | 6907 | 0.000 |
Why?
|